NM
Naresh Mahajan
About Naresh Mahajan
Data last updated:
Naresh Mahajan is a Director at Macmillon Pharmaceuticals Private Limited (since 1996), Director at Ravenbhel Pharmaceuticals Private Limited (since 2000) and Director at Neomac Pharmaceuticals Private Limited (since 2015), and holds 6 more current directorships. The companies operate in Pharma, Healthcare and Paper. The 5 current companies with reported revenue have a combined latest revenue of ₹125 Cr; the largest is Macmillon Pharmaceuticals Private Limited at ₹83.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Macmillon Pharmaceuticals Private Limited U24231PB1988PTC008661 | Director | 01 Apr 1996 | 1988 | ₹83.91 Cr (FY 2024) | Active |
 Ravenbhel Pharmaceuticals Private Limited U24232PB2000PTC024120 | Director | 12 Dec 2000 | 2000 | ₹25.73 Cr (FY 2024) | Active |
 Neomac Pharmaceuticals Private Limited U24232PB2015PTC039375 | Director | 10 Apr 2015 | 2015 | ₹8.43 Cr (FY 2024) | Active |
 Ravenmac Pharmaceuticals Private Limited U24232PB2010PTC033648 | Director | 03 Mar 2010 | 2010 | ₹7.34 Cr (FY 2025) | Active |
| Biovonic Healthcare Private Limited U24299JK2021PTC012575 | Director | 23 Jul 2021 | 2021 | ₹57,600 (FY 2024) | Active |
| Nys Hospitals Private Limited U86100PB2024PTC060652 | Director | 02 Feb 2024 | 2024 | Active | |
| Polycoatt Films Private Limited U21002JK2024PTC015446 | Director | 03 Jan 2024 | 2024 | Active | |
| Salutemlab Formulations Private Limited U21002JK2023PTC015130 | Director | 05 Oct 2023 | 2023 | Active |
Board colleagues of Naresh Mahajan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Asar Mohd Khan | 07053840 | Macmillon Pharmaceuticals Private Limited | Whole-Time Director |
| Sahil Mahajan | 00158373 | Macmillon Pharmaceuticals Private Limited , Ravenbhel Pharmaceuticals Private Limited and 7 more | Director |
| Satish Kumar | 07951655 | Macmillon Pharmaceuticals Private Limited | Director |
| Sanjay Khanna | 00158384 | Ravenbhel Pharmaceuticals Private Limited | Director |
| Sanjeev Kumar Sharma | 00158299 | Ravenbhel Pharmaceuticals Private Limited , Nys Hospitals Private Limited | Director |
| Yogesh Khanna | 00158367 | Ravenbhel Pharmaceuticals Private Limited , Nys Hospitals Private Limited | Director |
| Mohd Yaqub Mir | 07149881 | Neomac Pharmaceuticals Private Limited | Director |
| Shabir Ahmad Bhat | 07149894 | Neomac Pharmaceuticals Private Limited | Director |
| Amit Kumar | 02315829 | Biovonic Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naresh Mahajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naresh Mahajan
Naresh Mahajan currently holds 9 directorships: Macmillon Pharmaceuticals Private Limited (Director, since 01 Apr 1996, revenue ₹83.91 Cr (FY 2024)); Ravenbhel Pharmaceuticals Private Limited (Director, since 12 Dec 2000, revenue ₹25.73 Cr (FY 2024)); Neomac Pharmaceuticals Private Limited (Director, since 10 Apr 2015, revenue ₹8.43 Cr (FY 2024)); Ravenmac Pharmaceuticals Private Limited (Director, since 03 Mar 2010, revenue ₹7.34 Cr (FY 2025)); Biovonic Healthcare Private Limited (Director, since 23 Jul 2021, revenue ₹57,600 (FY 2024)); and 4 more.
Naresh Mahajan was first appointed on 01 Apr 1996 as Director at Macmillon Pharmaceuticals Private Limited. The most recent appointment on record is 02 Feb 2024 at Nys Hospitals Private Limited.
The 5 current companies of Naresh Mahajan that report revenue have a combined latest revenue of ₹125 Cr: Macmillon Pharmaceuticals Private Limited ₹83.91 Cr (FY 2024); Ravenbhel Pharmaceuticals Private Limited ₹25.73 Cr (FY 2024); Neomac Pharmaceuticals Private Limited ₹8.43 Cr (FY 2024); Ravenmac Pharmaceuticals Private Limited ₹7.34 Cr (FY 2025); Biovonic Healthcare Private Limited ₹57,600 (FY 2024).
The current boards of Naresh Mahajan's companies include Asar Mohd Khan (Macmillon Pharmaceuticals Private Limited), Sahil Mahajan (Macmillon Pharmaceuticals Private Limited), Satish Kumar (Macmillon Pharmaceuticals Private Limited), Sanjay Khanna (Ravenbhel Pharmaceuticals Private Limited), Sanjeev Kumar Sharma (Ravenbhel Pharmaceuticals Private Limited), Yogesh Khanna (Ravenbhel Pharmaceuticals Private Limited), among others.